Genestra HMF Replenish Capsules
Genestra HMF Replenish Capsules
Excellent 4.9
19,544 Reviews
Trustpilot
Designed & Developed in
Los Angeles, CA
Shopify Secure
400+ orders
in the last 24h
465 sold in the past 24 hours
401 people are viewing this item
Only 1% left in stock
Regular price
$6.59
Regular price
$6.59
Sale price
$9.99
Unit price
/
per
 
Couldn't load pickup availability
Genestra HMF Replenish Capsules
Regular price
$6.59
Regular price
$6.59
Sale price
$9.99
Unit price
/
per
check_box
🔒 Order with Confidence
🔒 Order with Confidence
✅30-Day Money Back Guarantee — no risk trying it.
🚚Free shipping available. Orders processed within 24–48 hours.
🔐Secure & encrypted checkout with trusted payment providers.
✈Order today, estimated delivery Oct 20 - Oct 21
♢Safe & secure checkout powered by Shopify
✓4–5 Business Day Delivery
✓90-Day Free Returns
✓Delivery available to United States
Reduces symptoms of IBS in adults and children
• Provides live microorganisms that form part of a natural healthy gut flora
• Proven to supplement the normal intestinal microbiota following antibiotic therapy
• Probiotics to significantly reduce symptoms of irritable bowel syndrome (IBS) in adult and children over 11 years
• Provides 100 billion CFU per dose from: Lactobacillus acidophilus (CUL-60), Lactobacillus acidophilus (CUL-21), Bifidobacterium bifidum (CUL-20), Bifidobacterium animalis subsp. lactis (CUL-34), Lactobacillus salivarius (CUL-61)
• Includes fructooligosaccharides (FOS)
HMF Replenish Capsules contain five strains of proprietary human-sourced probiotics that decrease IBS symptoms in adults and children. IBS affects nearly 5 million Canadians and can result from altered intestinal microflora.1,2 Lactobacilli and Bifidobacteria promote healthy intestinal microflora and increase the reabsorption of bile salts, which is impaired in IBS.1 This results in less water entering the colon to dilute the bile salts, decreasing water excretion and the occurrence of diarrhea.1 In a randomized, placebo-controlled trial involving 52 adults with IBS, daily supplementation with CUL-60, CUL-21, CUL-20 and CUL-34 significantly improved quality of life and bowel habit satisfaction scores, and decreased the number of days with pain within 10 weeks.3 Antibiotics also alter intestinal microflora, and can result in the proliferation of antibiotic-resistant bacteria.1 HMF Replenish Capsules promote normal intestinal microbiota following antibiotic therapy by further decreasing the pH and increasing mucin release to prevent pathogenic adherence to cells.4,5
View full details
• Provides live microorganisms that form part of a natural healthy gut flora
• Proven to supplement the normal intestinal microbiota following antibiotic therapy
• Probiotics to significantly reduce symptoms of irritable bowel syndrome (IBS) in adult and children over 11 years
• Provides 100 billion CFU per dose from: Lactobacillus acidophilus (CUL-60), Lactobacillus acidophilus (CUL-21), Bifidobacterium bifidum (CUL-20), Bifidobacterium animalis subsp. lactis (CUL-34), Lactobacillus salivarius (CUL-61)
• Includes fructooligosaccharides (FOS)
HMF Replenish Capsules contain five strains of proprietary human-sourced probiotics that decrease IBS symptoms in adults and children. IBS affects nearly 5 million Canadians and can result from altered intestinal microflora.1,2 Lactobacilli and Bifidobacteria promote healthy intestinal microflora and increase the reabsorption of bile salts, which is impaired in IBS.1 This results in less water entering the colon to dilute the bile salts, decreasing water excretion and the occurrence of diarrhea.1 In a randomized, placebo-controlled trial involving 52 adults with IBS, daily supplementation with CUL-60, CUL-21, CUL-20 and CUL-34 significantly improved quality of life and bowel habit satisfaction scores, and decreased the number of days with pain within 10 weeks.3 Antibiotics also alter intestinal microflora, and can result in the proliferation of antibiotic-resistant bacteria.1 HMF Replenish Capsules promote normal intestinal microbiota following antibiotic therapy by further decreasing the pH and increasing mucin release to prevent pathogenic adherence to cells.4,5
